Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)

Special NoticeActive

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Full and open competition - all businesses eligible to bid
  • Work to be performed in ABERDEEN PROVING GROU, MD
  • Industry: Research and Development in Biotechnology (except Nanobiotechnology)

Contract Details

Notice ID
W911SR-26-R-HEAL
Opportunity Type
Special Notice
Sub-Agency
DEPT OF THE ARMY
Office
W6QK ACC-APG
Posted Date
Tuesday, July 21, 2026
Response Deadline
Not specified
PSC Code
AC13
Set-Aside
Full & Open Competition
Status
Active

Description

This is a continuous, open announcement with no deadline unless specifically noted. (Please note this posting was formerly the Threat Agnostic Host-Directed Therapeutics/HEALER PBA. If a white paper was previously submitted under the HEALER name, then the submission is still valid for the revised annoucement.) 1. Strategic Opportunity: The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) invites interested parties to enter into the CBRN Medical Countermeasure (MCM) Participant Basic Agreement (PBA) ecosystem. This PBA establishes a unified, open, and continuous network of pre-qualified partners to accelerate the development, testing, and fielding of next-generation CBRN medical defense solutions. The goal is to create streamlined, framewo

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for research and development in biotechnology (except nanobiotechnology) in ABERDEEN PROVING GROU, MD.